Literature DB >> 22120980

Cervicovaginal human papillomavirus (HPV)-infection before and after hysterectomy: evidence of different tissue tropism for oncogenic and nononcogenic HPV types in a cohort of HIV-positive and HIV-negative women.

Gypsyamber D'Souza1, Robert D Burk, Ye Zhong, Howard Minkoff, L Stewart Massad, Xiaonan Xue, D Heather Watts, Kathryn Anastos, Joel M Palefsky, Alexandra M Levine, Christine Colie, Philip E Castle, Howard D Strickler.   

Abstract

Human papillomavirus (HPV) is detected in nearly all cervical cancers and approximately half of vaginal cancers. However, vaginal cancer is an order of magnitude less common than cervical cancer, not only in the general population but also among women with HIV/AIDS. It is interesting therefore that recent studies found that HPV was common in both normal vaginal and cervical tissue, with higher prevalence of nononcogenic HPV types in the vagina. In our investigation, we prospectively examined HPV infection in 86 HIV-positive and 17 HIV-negative women who underwent hysterectomy during follow-up in a longitudinal cohort. Cervicovaginal lavage specimens were obtained semi-annually and tested for HPV DNA by polymerase chain reaction. To address possible selection biases associated with having a hysterectomy, subjects acted as their own comparison group--before versus after hysterectomy. The average HPV prevalence was higher in HIV-positive than HIV-negative women both before (59% vs. 12%; p < 0.001) and after hysterectomy (56% vs. 6%; p < 0.001). Multivariate random effects models (within-individual comparisons) demonstrated significantly lower HPV prevalence [odds ratio (OR) = 0.71; 95% confidence interval (CI) = 0.59-0.85) after hysterectomy. The association of HPV prevalence with hysterectomy was similar among HIV-positive and HIV-negative women. However, hysterectomy had greater effects on oncogenic (OR = 0.48; 95% CI = 0.35-0.66) than nononcogenic HPV types (OR = 0.89; 95% CI = 0.71-1.11; P(interaction) = 0.002). Overall, we observed greater reductions in oncogenic than nononcogenic HPV prevalence after hysterectomy. If correct, these data could suggest that oncogenic HPV have greater tropism for cervical compared to vaginal epithelium, consistent with the lower incidence of vaginal than cervical cancer.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22120980      PMCID: PMC3321069          DOI: 10.1002/ijc.27363

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  Carcinogenicity of human papillomaviruses.

Authors:  Vincent Cogliano; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi
Journal:  Lancet Oncol       Date:  2005-04       Impact factor: 41.316

Review 2.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Elimination of false-positive signals in enhanced chemiluminescence (ECL) detection of amplified HPV DNA from clinical samples.

Authors:  G Jiang; W Qu; H Ruan; R D Burk
Journal:  Biotechniques       Date:  1995-10       Impact factor: 1.993

4.  Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus.

Authors:  Denise J Jamieson; Pangaja Paramsothy; Susan Cu-Uvin; Ann Duerr
Journal:  Obstet Gynecol       Date:  2006-05       Impact factor: 7.661

5.  PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

Authors:  W Qu; G Jiang; Y Cruz; C J Chang; G Y Ho; R S Klein; R D Burk
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

6.  Comparisons of HPV DNA detection by MY09/11 PCR methods.

Authors:  Philip E Castle; Mark Schiffman; Patti E Gravitt; Hortense Kendall; Stacy Fishman; Huali Dong; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Attila Lorincz; John E Schussler; Robert D Burk
Journal:  J Med Virol       Date:  2002-11       Impact factor: 2.327

7.  A population-based study of vaginal human papillomavirus infection in hysterectomized women.

Authors:  Philip E Castle; Mark Schiffman; M Concepcion Bratti; Allan Hildesheim; Rolando Herrero; Martha L Hutchinson; Ana Cecilia Rodriguez; Sholom Wacholder; Mark E Sherman; Hortense Kendall; Raphael P Viscidi; Jose Jeronimo; John E Schussler; Robert D Burk
Journal:  J Infect Dis       Date:  2004-07-02       Impact factor: 5.226

8.  Comparison of incident cervical and vulvar/vaginal human papillomavirus infections in newly sexually active young women.

Authors:  Rachel L Winer; James P Hughes; Qinghua Feng; Sandra O'Reilly; Nancy B Kiviat; Laura A Koutsky
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

9.  Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up.

Authors:  L Stewart Massad; Eric C Seaberg; Rodney L Wright; Teresa Darragh; Yi-Chun Lee; Christine Colie; Robert Burk; Howard D Strickler; D Heather Watts
Journal:  Obstet Gynecol       Date:  2008-06       Impact factor: 7.661

10.  A comparison of cervical and vaginal human papillomavirus.

Authors:  Philip E Castle; Ana C Rodriguez; Carolina Porras; Rolando Herrero; Mark Schiffman; Paula Gonzalez; Allan Hildesheim; Robert D Burk
Journal:  Sex Transm Dis       Date:  2007-11       Impact factor: 2.830

View more
  7 in total

1.  Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon.

Authors:  Adebola Adedimeji; Rogers Ajeh; Anastase Dzudie; Ernestine Kendowo; Norbert Fuhngwa; Denis Nsame; Andre Gaetan Simo-Wambo; Enow Orock; Tiffany M Hebert; Amanda J Pierz; Daniel Murokora; Kathryn Anastos; Philip E Castle
Journal:  J Clin Virol       Date:  2020-05-19       Impact factor: 3.168

2.  Long-term cumulative detection of human papillomavirus among HIV seropositive women.

Authors:  L Stewart Massad; Xianhong Xie; Robert Burk; Marla J Keller; Howard Minkoff; Gypsyamber DʼSouza; D Heather Watts; Joel Palefsky; Mary Young; Alexandra M Levine; Mardge Cohen; Howard D Strickler
Journal:  AIDS       Date:  2014-11-13       Impact factor: 4.177

3.  Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia.

Authors:  L Stewart Massad; Xianhong Xie; Ruth M Greenblatt; Howard Minkoff; Lorraine Sanchez-Keeland; D Heather Watts; Rodney L Wright; Gypsyamber D'Souza; Daniel Merenstein; Howard Strickler
Journal:  Obstet Gynecol       Date:  2012-03       Impact factor: 7.661

4.  Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.

Authors:  L Stewart Massad; Xianhong Xie; Howard L Minkoff; Katherine G Michel; Gypsyamber D'Souza; Chia-Ching Wang; Deborah Konkle-Parker; Igho Ofotokun; Margaret A Fischl; Lisa Rahangdale; Howard D Strickler
Journal:  Am J Obstet Gynecol       Date:  2021-05-03       Impact factor: 10.693

Review 5.  The Drivers, Mechanisms, and Consequences of Genome Instability in HPV-Driven Cancers.

Authors:  Vanessa L Porter; Marco A Marra
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

6.  Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda.

Authors:  Gad Murenzi; Jean-Claude Dusingize; Theogene Rurangwa; Jean d'Amour Sinayobye; Athanase Munyaneza; Anthere Murangwa; Thierry Zawadi; Tiffany Hebert; Pacifique Mugenzi; Adebola Adedimeji; Leon Mutesa; Kathryn Anastos; Philip E Castle
Journal:  BMJ Open       Date:  2018-08-05       Impact factor: 2.692

7.  Intra-host sequence variability in human papillomavirus.

Authors:  Racheal S Dube Mandishora; Kristina S Gjøtterud; Sonja Lagström; Babill Stray-Pedersen; Kerina Duri; Nyasha Chin'ombe; Mari Nygård; Irene Kraus Christiansen; Ole Herman Ambur; Mike Z Chirenje; Trine B Rounge
Journal:  Papillomavirus Res       Date:  2018-04-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.